Literature DB >> 26139838

Pathogenesis of Bolivian Hemorrhagic Fever in Guinea Pigs.

T M Bell1, T E Bunton2, C I Shaia3, J W Raymond4, S P Honnold4, G C Donnelly4, J D Shamblin4, E R Wilkinson4, K A Cashman4.   

Abstract

Machupo virus, the cause of Bolivian hemorrhagic fever, is a highly lethal viral hemorrhagic fever with no Food and Drug Administration-approved vaccines or therapeutics. This study evaluated the guinea pig as a model using the Machupo virus-Chicava strain administered via aerosol challenge. Guinea pigs (Cavia porcellus) were serially sampled to evaluate the temporal progression of infection, gross and histologic lesions, and sequential changes in serum chemistry and hematology. The incubation period was 5 to 12 days, and complete blood counts revealed leukopenia with lymphopenia and thrombocytopenia. Gross pathologic findings included congestion and hemorrhage of the gastrointestinal mucosa and serosa, noncollapsing lungs with fluid exudation, enlarged lymph nodes, and progressive pallor and friability of the liver. Histologic lesions consisted of foci of degeneration and cell death in the haired skin, liver, pancreas, adrenal glands, lymph nodes, tongue, esophagus, salivary glands, renal pelvis, small intestine, and large intestine. Lymphohistiocytic interstitial pneumonia was also present. Inflammation within the central nervous system, interpreted as nonsuppurative encephalitis, was histologically apparent approximately 16 days postexposure and was generally progressive. Macrophages in the tracheobronchial lymph node, on day 5 postexposure, were the first cells to demonstrate visible viral antigen. Viral antigen was detected throughout the lymphoid system by day 9 postexposure, followed by prominent spread within epithelial tissues and then brain. This study provides insight into the course of Machupo virus infection and supports the utility of guinea pigs as an additional animal model for vaccine and therapeutic development.
© The Author(s) 2015.

Entities:  

Keywords:  American; Bolivia; Cavia porcellus; Machupo virus; New World; aerosols; animal; arenaviruses; models; viral hemorrhagic fever

Mesh:

Substances:

Year:  2015        PMID: 26139838     DOI: 10.1177/0300985815588609

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  10 in total

1.  Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.

Authors:  Brady T Hickerson; Jonna B Westover; Zhongde Wang; Young-Min Lee; Brian B Gowen
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

2.  Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.

Authors:  Elizabeth J Mateer; Junki Maruyama; Galen E Card; Slobodan Paessler; Cheng Huang
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

3.  Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.

Authors:  Emily K Mantlo; Junki Maruyama; John T Manning; Timothy G Wanninger; Cheng Huang; Jeanon N Smith; Michael Patterson; Slobodan Paessler; Takaaki Koma
Journal:  J Virol       Date:  2022-03-28       Impact factor: 6.549

4.  Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.

Authors:  Joseph W Golden; Piet Maes; Steven A Kwilas; John Ballantyne; Jay W Hooper
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

5.  Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector.

Authors:  Dylan M Johnson; Jenny D Jokinen; Min Wang; Tia Pfeffer; Irina Tretyakova; Ricardo Carrion; Anthony Griffiths; Peter Pushko; Igor S Lukashevich
Journal:  Vaccine       Date:  2020-02-25       Impact factor: 3.641

6.  Description and characterization of a novel live-attenuated tri-segmented Machupo virus in Guinea pigs.

Authors:  Amélie D Zaza; Cécile H Herbreteau; Christophe N Peyrefitte
Journal:  Virol J       Date:  2018-06-07       Impact factor: 4.099

Review 7.  Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors.

Authors:  Morgan E Brisse; Hinh Ly
Journal:  Front Immunol       Date:  2019-03-13       Impact factor: 7.561

8.  Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections.

Authors:  Brady T Hickerson; Tracy R Daniels-Wells; Cristian Payes; Lars E Clark; Pierre V Candelaria; Kevin W Bailey; Eric J Sefing; Samantha Zink; James Ziegenbein; Jonathan Abraham; Gustavo Helguera; Manuel L Penichet; Brian B Gowen
Journal:  Nat Commun       Date:  2022-01-28       Impact factor: 17.694

Review 9.  Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses.

Authors:  Emily Mantlo; Slobodan Paessler; Cheng Huang
Journal:  Vaccines (Basel)       Date:  2019-10-02

Review 10.  Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response.

Authors:  Bryce M Warner
Journal:  Pathogens       Date:  2021-03-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.